Notice of Correction to RFA-CA-22-050, NCI Cancer Moonshot Scholars Diversity Program (CMSDP) (R01 Clinical Trial Optional)".
Notice NOT-CA-22-132 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - November 22, 2022 Category: Research Source Type: funding
Mechanistic links between diet, lipid metabolism, and tumor growth and progression (U01 Clinical Trial Not Allowed)
Funding Opportunity PAR-23-051 from the NIH Guide for Grants and Contracts. The purpose of this funding opportunity announcement is to request applications that propose mechanistic investigations of the links between diet, lipid metabolism and tumor growth and progression. It is anticipated that this program will support fundamental studies designed to identify and define the molecular mechanisms through which lipid metabolism mediates tumor growth and progression, focusing specifically on the central role lipids play in linking diet with the biology of cancer; bridge the historically divided fields of nutrition and mol...
Source: NIH Funding Opportunities (Notices, PA, RFA) - November 21, 2022 Category: Research Source Type: funding
Mechanistic links between diet, lipid metabolism, and tumor growth and progression (UH2 Clinical Trial Not Allowed)
Funding Opportunity PAR-23-052 from the NIH Guide for Grants and Contracts. The purpose of this funding opportunity announcement is to request applications that propose mechanistic investigations of the links between diet, lipid metabolism and tumor growth and progression. It is anticipated that this program will support fundamental studies designed to identify and define the molecular mechanisms through which lipid metabolism mediates tumor growth and progression, focusing specifically on the central role lipids play in linking diet with the biology of cancer; bridge the historically divided fields of nutrition and mol...
Source: NIH Funding Opportunities (Notices, PA, RFA) - November 21, 2022 Category: Research Source Type: funding
Request for Information: Priorities for Cancer Prevention and Symptom Management Science at NCI
Notice NOT-CA-23-016 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - November 21, 2022 Category: Research Source Type: funding
NCI Cancer Screening Research Network: Coordinating and Communication Center (UG1 Clinical Trial Required)
Funding Opportunity RFA-CA-23-022 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) is one of three FOAs that will support a comprehensive effort by the National Cancer Institute (NCI) to provide infrastructure to develop and conduct national cancer screening clinical trials and studies through the Cancer Screening Research Network (CSRN). The primary goal of the CSRN is the conduct of multi-center cancer screening trials and studies. This Network is designed to take advantage of large and diverse populations receiving routine care in a variety of healthcare settings. The CSRN will...
Source: NIH Funding Opportunities (Notices, PA, RFA) - November 17, 2022 Category: Research Source Type: funding
NCI Cancer Screening Research Network: Statistics and Data Management Center (UG1 Clinical Trial Required)
Funding Opportunity RFA-CA-23-021 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) is one of three FOAs that will support a comprehensive effort by the National Cancer Institute (NCI) to provide infrastructure to develop and conduct national cancer screening clinical trials and studies through the Cancer Screening Research Network (CSRN). The primary goal of the CSRN is the conduct of multi-center cancer screening trials and studies. This Network is designed to take advantage of large and diverse populations receiving routine care in a variety of healthcare settings. The CSRN will...
Source: NIH Funding Opportunities (Notices, PA, RFA) - November 17, 2022 Category: Research Source Type: funding
NCI Cancer Screening Research Network: ACCrual, Enrollment, and Screening Sites (ACCESS) Hub (UG1 Clinical Trial Required)
Funding Opportunity RFA-CA-23-020 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) is one of three FOAs that will support a comprehensive effort by the National Cancer Institute (NCI) to provide infrastructure to develop and conduct national cancer screening clinical trials and studies through the Cancer Screening Research Network (CSRN). The primary goal of the CSRN is the conduct of multi-center cancer screening trials and studies. This Network is designed to take advantage of large and diverse populations receiving routine care in a variety of healthcare settings. The CSRN will...
Source: NIH Funding Opportunities (Notices, PA, RFA) - November 17, 2022 Category: Research Source Type: funding
Notice of Special Interest (NOSI): Administrative Supplement for NCI Cancer Prevention-Interception Targeted Agent Discovery Program (CAP-IT)
Notice NOT-CA-23-012 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - November 16, 2022 Category: Research Source Type: funding
Transformative Educational Advancement and Mentoring Network (TEAM) (R25 Clinical Trial Not Allowed)
Funding Opportunity RFA-CA-23-013 from the NIH Guide for Grants and Contracts. The NIH Research Education Program (R25) supports research education activities in the mission areas of the NIH. The overarching goal of this NCI R25 program is to support research and educational activities that enhance the diversity of the cancer biomedical workforce. We seek to do this by providing training navigation to support scholars from diverse backgrounds, including individuals from groups shown to be underrepresented in the cancer biomedical workforce. The TEAM program will pilot test the use of training champions (TCs) at minority...
Source: NIH Funding Opportunities (Notices, PA, RFA) - November 8, 2022 Category: Research Source Type: funding
Notice of Correction to Application Types Allowed in PAR-22-239, Feasibility Studies to Build Collaborative Partnerships in Cancer Research (P20 Clinical Trial Not Allowed)
Notice NOT-CA-23-010 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - November 1, 2022 Category: Research Source Type: funding
Precompetitive Collaboration on Liquid Biopsy for Early Cancer Assessment: Data Management and Coordinating Unit (U24 Clinical Trial Not Allowed)
The objectives of the Early Detection Research Network (EDRN; edrn.cancer.gov) are to discover, develop and validate biomarkers and imaging methods to detect early stage cancers and to translate these into clinical tests. The EDRN provides an infrastructure that is essential for this process and has successfully completed more than 10 multicenter validation studies. (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - October 31, 2022 Category: Research Source Type: funding
Precompetitive Collaboration on Liquid Biopsy for Early Cancer Assessment: Liquid Biopsy Research Laboratories (U01 Clinical Trial Not Allowed)
Funding Opportunity RFA-CA-23-018 from the NIH Guide for Grants and Contracts. The purpose of this initiative is to establish an Academic-Industrial Partnership Program to develop new and/or validate existing technologies, methods, and assays for the capture and quantification of tumor associated cells, DNA, RNA, or exosomes in body fluids of patients with early stage disease or those at high risk; as well as distinguishing cancer from benign disease; or aggressive from indolent cancers. The precompetitive alliances with industry will harmonize and validate technologies, methods and assays associated with liquid biopsie...
Source: NIH Funding Opportunities (Notices, PA, RFA) - October 31, 2022 Category: Research Source Type: funding
Comprehensive Partnerships to Advance Cancer Health Equity (CPACHE) (U54 Clinical Trial Optional)
Funding Opportunity PAR-22-249 from the NIH Guide for Grants and Contracts. This funding opportunity seeks to support the Comprehensive Partnerships to Advance Cancer Health Equity (CPACHE) Program. The CPACHE Program develops and maintains comprehensive, long-term, and mutually beneficial partnerships between institutions serving underserved health disparity populations and underrepresented students (ISUPSs) and NCI-designated Cancer Centers (CCs). The program aims to achieve a more robust national cancer program and address challenges in cancer and cancer disparities research, education, and outreach, as well as their...
Source: NIH Funding Opportunities (Notices, PA, RFA) - October 26, 2022 Category: Research Source Type: funding
Feasibility Studies to Build Collaborative Partnerships in Cancer Research (P20 Clinical Trial Not Allowed)
Funding Opportunity PAR-22-239 from the NIH Guide for Grants and Contracts. Through this Funding Opportunity Announcement (FOA), the National Cancer Institute (NCI) invites P20 planning grant applications for developing collaborative partnership between institutions serving underserved health disparity populations and underrepresented students (ISUPS) and NCI- designated Cancer Centers (or Cancer Centers with highly integrated cancer research programs). This FOA is designed to facilitate the planning and execution of focused collaborations in cancer-related research, research experience, and research education. A major ...
Source: NIH Funding Opportunities (Notices, PA, RFA) - October 26, 2022 Category: Research Source Type: funding
Utilizing Telomere Status to Reveal Molecular Mechanisms Underlying Susceptibility and Resiliency in Response to Environmental Exposures (R01 Clinical Trial Not Allowed)
Funding Opportunity RFA-ES-22-007 from the NIH Guide for Grants and Contracts. The purpose of this funding opportunity announcement (FOA) is to solicit applications that further examine and characterize molecular underpinnings surrounding telomere status and accompanying biological pathways in response to environmental insults. Specifically, the intent is to further stimulate the field on how general telomere maintenance modulates downstream biological pathway(s) leading to cellular and organismal dysfunction. It is anticipated that proposed studies examining exposure affects at telomeric regions can actually potentiate...
Source: NIH Funding Opportunities (Notices, PA, RFA) - October 21, 2022 Category: Research Source Type: funding
